Oncology Information Systems Market Size, Trends & Growth Opportunity By System Type (Radiation Oncology, Medical Oncology, Integrated Care Platforms), By Deployment Model (On-Premise, Cloud, Hybrid), By Institution Type (Specialized Cancer Hospitals, Academic Centers), By End User (Radiation Oncologists, Hospital IT), By Region and Forecast Till 2030

Report ID : AMR1005844 | Industries : Healthcare | Published On :August 2026 | Page Count : 279

Request Sample
Ask for Customization

Oncology Information Systems Market Overview & Definition

The oncology information systems market covers the radiation oncology information systems, medical oncology information systems, integrated oncology care platforms and oncology electronic medical records that hospitals, cancer centers and clinical teams use to manage treatment planning, chemotherapy workflow, clinical documentation and outcomes reporting across the cancer care continuum.

This market occupies a distinct and growing position within broader healthcare IT, valued for its direct role in coordinating multidisciplinary cancer care across radiation oncology, medical oncology and surgical oncology teams that must work from a shared, accurate clinical record.

Brazil anchors demand for this report's scope, reflecting the country's expanding hospital digitalization programs, growing radiotherapy infrastructure investment and a large, geographically concentrated base of high-volume oncology centers spanning both public and private healthcare systems.

The market spans a wide range of system types, deployment models, healthcare institution types and end users, from radiation oncology directors at high-volume treatment centers to hospital IT departments managing multi-system interoperability across an entire hospital network.

Buyer sophistication continues to rise across this market, with hospital CIOs and oncology department heads increasingly evaluating platforms not just on core clinical functionality but on interoperability, cloud readiness and long-term vendor support capability.

As a category, oncology information systems sit at the intersection of clinical oncology practice and healthcare IT infrastructure, a combination that has made it one of the more closely watched digitalization priorities within Brazil's broader healthcare modernization agenda.

Data integration continues to deepen across this market, with modern platforms increasingly expected to unify treatment records, imaging references and outcomes data that were traditionally siloed across separate departmental systems.

As a category, oncology information systems have moved from a narrow radiotherapy-only tool to a broader cancer care coordination platform, reflecting how multidisciplinary the modern oncology care pathway has become.

Interoperability has become a defining evaluation theme across the category, with institutions increasingly unwilling to accept a platform that cannot exchange data cleanly with their existing imaging, pharmacy and general hospital record systems.

Market Size & Growth Forecast (2026 to 2030)

The oncology information systems market in Brazil is estimated at approximately USD 115 Million in 2025 and is projected to reach approximately USD 173 Million by 2030, expanding at a compound annual growth rate of roughly 8.5 percent across the forecast period, reflecting accelerating hospital digitalization and radiotherapy infrastructure investment nationwide.

Brazil represents the largest single market within Latin America for oncology information systems, reflecting its concentrated base of high-volume radiotherapy centers and private oncology chains relative to other countries in the region.

Integrated oncology care platforms and cloud-based deployment models are expected to grow fastest across the forecast period, as institutions increasingly favor unified, interoperable systems over standalone, single-function tools.

MetricValue
Market Size (2025)Approximately USD 115 Million
Forecast Size (2030)Approximately USD 173 Million
CAGR (2025-2030)Approximately 8.5%
Base Year2025
Forecast Period2026-2030 (5-year)
Largest System TypeRadiation oncology information systems
Fastest-Growing Deployment ModelCloud-based and hybrid deployment models
Leading Regional Demand CenterSao Paulo Metropolitan Oncology Network
Key Growth DriverHospital digitalization and radiotherapy infrastructure investment
Market StructureMixed, with global vendors and regional Brazilian specialists

Market Drivers

Rapid hospital digitalization programs across Brazil's public and private oncology networks accelerating OIS adoption to replace legacy paper-based and siloed clinical workflows.

Growing radiotherapy infrastructure investment across Brazil, particularly at high-volume centers, increasing demand for treatment planning integration and dose management functionality.

Rising demand for interoperability with imaging, PACS and hospital-wide electronic medical record systems as cancer care becomes more multidisciplinary.

Government oncology infrastructure programs and public tender-based procurement expanding OIS deployment beyond the largest private hospital networks into mid-sized and regional institutions.

Growing AI and analytics adoption interest among oncology departments seeking to improve treatment outcomes tracking and clinical decision support.

Rising cancer incidence nationally, which continues to expand the total addressable base of institutions requiring dedicated oncology-specific clinical software.

Expanding private health insurance coverage in Brazil, which continues to fund a growing share of cancer treatment and, indirectly, the IT infrastructure investment private oncology chains make to support it.

Market Restraints

Limited interoperability in legacy hospital IT environments, complicating OIS integration at institutions still running older, siloed clinical systems.

Budget constraints among mid-sized and regional cancer centers relative to the capital intensity of enterprise-grade oncology information systems.

Vendor lock-in risk associated with deep radiotherapy ecosystem integration, which can complicate future platform migration decisions for buyers.

Facility budget cycles that do not align with a vendor's fiscal calendar can further complicate procurement timing, occasionally delaying platform decisions by a full budget cycle.

Workforce shortages in specialized IT and clinical engineering roles, particularly outside the largest metropolitan areas, which can slow implementation timelines even where budget is available.

Market Opportunities

Considerable untapped opportunity in regional oncology networks not yet meaningfully served by leading OIS vendors.

Multi-site workflow standardization opportunities as hospital groups consolidate oncology operations across multiple facilities.

Cloud migration support services as institutions transition from on-premise to cloud-based or hybrid deployment models.

Localized oncology analytics offerings addressing a gap most global vendors have not yet fully closed for the Brazilian market.

Vendors that can demonstrate clear interoperability and compliance readiness alongside proven clinical workflow depth are best positioned to capture this opportunity as hospital purchasing committees weigh both dimensions jointly.

Partnership opportunities between global platform vendors and Brazilian systems integrators, combining international clinical depth with the local compliance and support infrastructure institutions increasingly expect.

System Types and Deployment Models

The market spans radiation oncology, medical oncology and integrated oncology care platforms, each deployable on-premise, in the cloud or through a hybrid model, with integration complexity ranging from standalone environments to full enterprise oncology ecosystems. Full segmentation detail is covered on the oncology information system types and deployment models page.

Institution size and existing IT infrastructure typically determine which deployment model and integration complexity level a given buyer can realistically pursue.

Deployment model choice increasingly reflects an institution's IT maturity as much as its budget, with cloud-based and hybrid models gaining ground even among larger hospitals that once defaulted to on-premise infrastructure.

Clinical Functionality and Oncology Modalities

Treatment planning integration, dose management, chemotherapy workflow management, clinical documentation, tumor board collaboration and research and clinical trial management each shape demand differently across radiation, medical and surgical oncology modalities. The full breakdown appears on the oncology information systems clinical functionality and modalities page.

Multidisciplinary institutions increasingly require functionality spanning multiple modalities simultaneously, rather than a single-modality tool serving one department in isolation.

Functionality depth continues to expand across the market, with platforms increasingly expected to support not just core clinical workflow but also outcomes analytics and research-grade data capture.

Healthcare Institution Types and End Users

Specialized cancer hospitals, academic and research cancer centers, private oncology networks, oncology departments in general hospitals, ambulatory oncology clinics and government cancer institutes each represent distinct end user profiles spanning radiation oncologists, medical oncologists, oncology nurses and hospital IT departments. Full institution type and end user detail is covered on the oncology information systems healthcare institution types and end users page.

End user needs continue to diversify as multidisciplinary cancer care becomes standard practice, requiring platforms to serve radiation oncologists, medical oncologists and hospital IT departments simultaneously rather than any single role in isolation.

Procurement Models and Regulatory Compliance

Direct enterprise procurement, multi-hospital procurement contracts, public tender-based procurement and managed IT service partnerships each carry distinct requirements for LGPD compliance, ANVISA integration, HL7/FHIR compatibility and DICOM integration. Full detail is covered on the oncology information systems procurement models and regulatory compliance page.

Compliance expectations continue to rise across all procurement models, with even smaller direct enterprise purchases now routinely requiring the same LGPD and ANVISA documentation once reserved for the largest public tenders.

Oncology Information Systems Market, By Region

Sao Paulo represents the market's largest single demand center, anchored by the Sao Paulo Metropolitan Oncology Network and the Campinas Healthcare Technology Corridor, both of which concentrate a significant share of the country's high-volume radiotherapy centers and private oncology chains.

The Barretos Oncology and Research Cluster forms a nationally significant demand center in its own right, reflecting its role as a major cancer research and treatment concentration beyond the Sao Paulo metropolitan area.

Southern Brazil, spanning Porto Alegre and Curitiba, represents a fast-growing private hospital network demand cluster, while Rio de Janeiro, Minas Gerais and the Distrito Federal each contribute meaningful additional public and academic sector demand.

Rio de Janeiro, Minas Gerais and the Distrito Federal each maintain a mix of large public hospital oncology departments and growing private sector investment, reflecting Brazil's broader pattern of concentrated metropolitan demand alongside steadily expanding regional coverage.

Leading Oncology Information Systems Companies

Elekta, Varian Medical Systems, RaySearch Laboratories, Philips Healthcare, Oracle Health, Epic Systems, Siemens Healthineers, Brainlab, InterSystems, MV Informatica, Benner Saude, Pixeon, TOTVS Saude, Cerner Enviza and Instituto de Cancer Dr. Arnaldo together shape the market's competitive landscape. A full, non-ranked overview of the companies leading the oncology information systems market is available on our companies page.

Beyond This Page

Hospitals, IT departments and investors making a market-entry, expansion or procurement decision on the strength of the public segmentation covered on these pages alone are working from directional signal rather than decision-grade detail. Category-level description of system types, functionality and institution types explains the shape of this market, but it does not tell a hospital which specific named vendor holds the strongest position in a given region, what a comparable platform is actually priced at, or how a specific institution type moves through its own procurement cycle, the detail an expansion or procurement decision genuinely depends on.

That gap has real consequences at the point a hospital or vendor commits capital to this market. Without the buyer intelligence, competitive benchmarking and company-level profiles the full report adds, a decision-maker is left choosing which system type to invest in, which region to prioritize, or which deployment model to pursue on category-level description alone, a considerably weaker basis for that decision than the underlying report data provides.

Hospitals and vendors proceeding on directional signal alone risk misallocating capital toward the wrong system type, region or deployment model relative to what a fully informed, data-backed decision would support.

Frequently Asked Questions

The market is estimated at approximately USD 115 million in 2025 and is projected to reach approximately USD 173 million by 2030, growing at around 8.5 percent annually.

Rapid hospital digitalization programs, growing radiotherapy infrastructure investment and rising demand for interoperability with imaging and electronic medical record systems are the primary drivers.

Radiation oncology information systems, medical oncology information systems, integrated oncology care platforms, oncology electronic medical records and oncology workflow automation platforms are the main system types.

Elekta, Varian Medical Systems, RaySearch Laboratories, Philips Healthcare, Oracle Health and Epic Systems are among the largest global players, alongside Brazilian specialists such as MV Informatica, Pixeon and TOTVS Saude.

Sao Paulo leads adoption, anchored by the Sao Paulo Metropolitan Oncology Network and Campinas Healthcare Technology Corridor, followed by the Barretos Oncology and Research Cluster and Southern Brazil's private hospital networks.

Inquire Before Buying Request Free Sample Ask For Discount

1. Introduction

1.1. Objective of the Study

1.2. Market Definition

1.3. Market Scope

2. Executive Summary

3. Oncology Information Systems Market - Brazil Focused View with Spotlight on Hospital Oncology Networks, Radiotherapy Workflow Integration and Cancer Care Digitalization Market Analysis and Forecast (2026–2030)

3.1. Overview

3.2. Market Dynamics

3.3. Drivers

3.3.1. Rapid Hospital Digitalization Programs Across Brazil's Public and Private Oncology Networks Accelerating OIS Adoption to Replace Legacy Paper-Based and Siloed Clinical Workflows.

3.3.2. Growing Radiotherapy Infrastructure Investment Across Brazil, Particularly at High-Volume Centers, Increasing Demand for Treatment Planning Integration and Dose Management Functionality.

3.3.3. Rising Demand for Interoperability with Imaging, PACS and Hospital-Wide Electronic Medical Record Systems as Cancer Care Becomes More Multidisciplinary.

3.3.4. Government Oncology Infrastructure Programs and Public Tender-Based Procurement Expanding OIS Deployment Beyond the Largest Private Hospital Networks into Mid-Sized and Regional Institutions.

3.3.5. Growing AI and Analytics Adoption Interest Among Oncology Departments Seeking to Improve Treatment Outcomes Tracking and Clinical Decision Support.

3.4. Restraints

3.4.1. Limited Interoperability in Legacy Hospital IT Environments, Complicating OIS Integration at Institutions Still Running Older, Siloed Clinical Systems.

3.4.2. Budget Constraints Among Mid-Sized and Regional Cancer Centers Relative to the Capital Intensity of Enterprise-Grade Oncology Information Systems.

3.4.3. Vendor Lock-in Risk Associated with Deep Radiotherapy Ecosystem Integration, Which Can Complicate Future Platform Migration Decisions for Buyers.

3.5. Opportunities

3.5.1. Considerable Untapped Opportunity in Regional Oncology Networks Not Yet Meaningfully Served by Leading OIS Vendors.

3.5.2. Multi-Site Workflow Standardization Opportunities as Hospital Groups Consolidate Oncology Operations Across Multiple Facilities.

3.5.3. Cloud Migration Support Services as Institutions Transition from On-Premise to Cloud-Based or Hybrid Deployment Models.

3.5.4. Localized Oncology Analytics Offerings Addressing a Gap Most Global Vendors Have Not Yet Fully Closed for the Brazilian Market.

3.6. Porter's Five Forces Model

3.7. Value Chain Analysis

4. Oncology Information Systems Market - Brazil Focused View with Spotlight on Hospital Oncology Networks, Radiotherapy Workflow Integration and Cancer Care Digitalization, By System Type

4.1. Radiation Oncology Information Systems

4.2. Medical Oncology Information Systems

4.3. Integrated Oncology Care Platforms

4.4. Oncology Electronic Medical Records

4.5. Oncology Treatment Planning Management Systems

4.6. Oncology Workflow Automation Platforms

4.7. Clinical Decision Support Systems

4.8. Patient Engagement and Survivorship Platforms

5. Oncology Information Systems Market - Brazil Focused View with Spotlight on Hospital Oncology Networks, Radiotherapy Workflow Integration and Cancer Care Digitalization, By Deployment Model

5.1. On-Premise Systems

5.2. Cloud-Based Systems

5.3. Hybrid Deployment Models

6. Oncology Information Systems Market - Brazil Focused View with Spotlight on Hospital Oncology Networks, Radiotherapy Workflow Integration and Cancer Care Digitalization, By Functionality

6.1. Patient Registration and Scheduling

6.2. Treatment Planning Integration

6.3. Dose Management and Verification

6.4. Chemotherapy Workflow Management

6.5. Clinical Documentation

6.6. Oncology Billing and Reimbursement

6.7. Imaging and PACS Integration

6.8. Analytics and Outcomes Reporting

6.9. Tumor Board Collaboration Tools

6.10. Research and Clinical Trial Management

7. Oncology Information Systems Market - Brazil Focused View with Spotlight on Hospital Oncology Networks, Radiotherapy Workflow Integration and Cancer Care Digitalization, By Oncology Modality

7.1. Radiation Oncology

7.2. Medical Oncology

7.3. Surgical Oncology

7.4. Integrated Multidisciplinary Oncology Programs

8. Oncology Information Systems Market - Brazil Focused View with Spotlight on Hospital Oncology Networks, Radiotherapy Workflow Integration and Cancer Care Digitalization, By Healthcare Institution Type

8.1. Specialized Cancer Hospitals

8.2. Oncology Departments in General Hospitals

8.3. Private Oncology Networks

8.4. Academic and Research Cancer Centers

8.5. Ambulatory Oncology Clinics

8.6. Government Cancer Institutes

9. Oncology Information Systems Market - Brazil Focused View with Spotlight on Hospital Oncology Networks, Radiotherapy Workflow Integration and Cancer Care Digitalization, By End User

9.1. Radiation Oncologists

9.2. Medical Oncologists

9.3. Oncology Nurses

9.4. Hospital IT Departments

9.5. Clinical Administrators

9.6. Physicists and Dosimetrists

9.7. Oncology Researchers

10. Oncology Information Systems Market - Brazil Focused View with Spotlight on Hospital Oncology Networks, Radiotherapy Workflow Integration and Cancer Care Digitalization, By Integration Complexity

10.1. Standalone OIS Environments

10.2. Multi-System Interoperability Deployments

10.3. Enterprise Oncology Ecosystems

11. Oncology Information Systems Market - Brazil Focused View with Spotlight on Hospital Oncology Networks, Radiotherapy Workflow Integration and Cancer Care Digitalization, By Procurement Model

11.1. Direct Enterprise Procurement

11.2. Multi-Hospital Procurement Contracts

11.3. Public Tender-Based Procurement

11.4. Managed IT Service Partnerships

12. Oncology Information Systems Market - Brazil Focused View with Spotlight on Hospital Oncology Networks, Radiotherapy Workflow Integration and Cancer Care Digitalization, By Regulatory and Compliance Alignment

12.1. LGPD-Compliant Oncology Platforms

12.2. ANVISA-Integrated Clinical Systems

12.3. HL7/FHIR Compatible Platforms

12.4. DICOM-Integrated Oncology Systems

13. Buyer Intelligence and Demand Landscape

13.1. Buyer Segmentation Across Public and Private Oncology Institutions

13.2. Large Hospital Groups Versus Independent Cancer Centers

13.3. Regional Oncology Procurement Patterns

13.4. Government Oncology Infrastructure Programs

13.5. Oncology IT Investment Priorities

13.6. Budget Ownership Structure in Cancer Institutions

13.7. Procurement Decision-Maker Mapping

13.7.1. General Directors

13.7.2. CIOs

13.7.3. Oncology Department Heads

13.7.4. Radiation Oncology Directors

13.7.5. Clinical Engineering Teams

13.8. Vendor Selection Criteria

13.8.1. Interoperability

13.8.2. Clinical Accuracy

13.8.3. Radiotherapy Compatibility

13.8.4. Service Support

13.8.5. Compliance Readiness

13.9. Procurement Lifecycle and Approval Flow

13.10. Typical Contract Value Bands

13.11. Replacement Versus Greenfield OIS Deployments

13.12. Buyer Concerns Around Downtime and Migration

13.13. Integration Demand with Varian/Elekta Ecosystems

13.14. AI and Analytics Adoption Interest

14. Brazil Market Analysis and Forecast (2026–2030)

14.1. Introduction

14.2. Market Share Analysis

14.3. Market Size and Forecast

14.4. Market Size and Forecast, By Geography

14.4.1. Sao Paulo

14.4.1.1. Market Share Analysis

14.4.1.2. Market Size and Forecast

14.4.1.3. By Product

14.4.1.4. By Technology

14.4.1.5. By Application

14.4.1.6. By Customer

14.4.2. Rio De Janeiro

14.4.2.1. Market Share Analysis

14.4.2.2. Market Size and Forecast

14.4.2.3. By Product

14.4.2.4. By Technology

14.4.2.5. By Application

14.4.2.6. By Customer

14.4.3. Minas Gerais

14.4.3.1. Market Share Analysis

14.4.3.2. Market Size and Forecast

14.4.3.3. By Product

14.4.3.4. By Technology

14.4.3.5. By Application

14.4.3.6. By Customer

14.4.4. Parana

14.4.4.1. Market Share Analysis

14.4.4.2. Market Size and Forecast

14.4.4.3. By Product

14.4.4.4. By Technology

14.4.4.5. By Application

14.4.4.6. By Customer

14.4.5. Rio Grande Do Sul

14.4.5.1. Market Share Analysis

14.4.5.2. Market Size and Forecast

14.4.5.3. By Product

14.4.5.4. By Technology

14.4.5.5. By Application

14.4.5.6. By Customer

14.4.6. Distrito Federal

14.4.6.1. Market Share Analysis

14.4.6.2. Market Size and Forecast

14.4.6.3. By Product

14.4.6.4. By Technology

14.4.6.5. By Application

14.4.6.6. By Customer

14.4.7. Campinas

14.4.7.1. Market Share Analysis

14.4.7.2. Market Size and Forecast

14.4.7.3. By Product

14.4.7.4. By Technology

14.4.7.5. By Application

14.4.7.6. By Customer

14.4.8. Barretos

14.4.8.1. Market Share Analysis

14.4.8.2. Market Size and Forecast

14.4.8.3. By Product

14.4.8.4. By Technology

14.4.8.5. By Application

14.4.8.6. By Customer

14.4.9. Porto Alegre

14.4.9.1. Market Share Analysis

14.4.9.2. Market Size and Forecast

14.4.9.3. By Product

14.4.9.4. By Technology

14.4.9.5. By Application

14.4.9.6. By Customer

14.4.10. Curitiba

14.4.10.1. Market Share Analysis

14.4.10.2. Market Size and Forecast

14.4.10.3. By Product

14.4.10.4. By Technology

14.4.10.5. By Application

14.4.10.6. By Customer

15. Competition Analysis

15.1. Market Positioning Overview

15.1.1. Global OIS Vendors Operating in Brazil

15.1.2. Regional Healthcare IT Providers

15.1.3. Hospital Integration Specialists

15.1.4. Oncology Workflow Platform Providers

15.1.5. Radiotherapy-Centric Versus Enterprise Oncology Vendors

15.1.6. Premium Versus Mid-Market Positioning

15.2. Competitive Benchmarking Metrics

15.2.1. Installed Base Presence

15.2.2. Radiotherapy Integration Capability

15.2.3. Clinical Workflow Depth

15.2.4. Cloud Readiness

15.2.5. Service and Maintenance Infrastructure

15.2.6. Localization Capability

15.2.7. Interoperability Standards Support

15.2.8. Pricing and Licensing Models

15.2.9. Training and Support Capability

15.2.10. Innovation and AI Readiness

15.3. Strategic Moves

15.3.1. Partnerships with Oncology Centers

15.3.2. Hospital Digitalization Initiatives

15.3.3. AI Oncology Platform Launches

15.3.4. Radiotherapy Workflow Integration Expansions

15.3.5. Healthcare Cloud Collaborations

15.3.6. Oncology Data Platform Investments

15.4. Competitive Mapping & Gaps

15.4.1. Underserved Mid-Sized Cancer Centers

15.4.2. Limited Interoperability in Legacy Environments

15.4.3. Considerable Untapped Opportunity in Regional Oncology Networks

15.4.4. Opportunity in Multi-Site Workflow Standardization

15.4.5. Gaps in Localized Oncology Analytics

15.4.6. Opportunities in Cloud Migration Support

16. Company Profiles

16.1. Elekta

16.1.1. Overview (HQ, Ownership, Founding Year, Workforce Estimate)

16.1.2. Geographic Footprint

16.1.3. Product and Service Portfolio

16.1.4. Target Customer Segments

16.1.5. Distribution and GTM

16.1.6. Key Financials

16.1.7. Certifications

16.1.8. Partnerships and Alliances

16.1.9. R&D and Innovation

16.1.10. Recent Developments

16.1.11. SWOT Snapshot

16.2. Varian Medical Systems

16.2.1. Overview (HQ, Ownership, Founding Year, Workforce Estimate)

16.2.2. Geographic Footprint

16.2.3. Product and Service Portfolio

16.2.4. Target Customer Segments

16.2.5. Distribution and GTM

16.2.6. Key Financials

16.2.7. Certifications

16.2.8. Partnerships and Alliances

16.2.9. R&D and Innovation

16.2.10. Recent Developments

16.2.11. SWOT Snapshot

16.3. RaySearch Laboratories

16.3.1. Overview (HQ, Ownership, Founding Year, Workforce Estimate)

16.3.2. Geographic Footprint

16.3.3. Product and Service Portfolio

16.3.4. Target Customer Segments

16.3.5. Distribution and GTM

16.3.6. Key Financials

16.3.7. Certifications

16.3.8. Partnerships and Alliances

16.3.9. R&D and Innovation

16.3.10. Recent Developments

16.3.11. SWOT Snapshot

16.4. Philips Healthcare

16.4.1. Overview (HQ, Ownership, Founding Year, Workforce Estimate)

16.4.2. Geographic Footprint

16.4.3. Product and Service Portfolio

16.4.4. Target Customer Segments

16.4.5. Distribution and GTM

16.4.6. Key Financials

16.4.7. Certifications

16.4.8. Partnerships and Alliances

16.4.9. R&D and Innovation

16.4.10. Recent Developments

16.4.11. SWOT Snapshot

16.5. Oracle Health

16.5.1. Overview (HQ, Ownership, Founding Year, Workforce Estimate)

16.5.2. Geographic Footprint

16.5.3. Product and Service Portfolio

16.5.4. Target Customer Segments

16.5.5. Distribution and GTM

16.5.6. Key Financials

16.5.7. Certifications

16.5.8. Partnerships and Alliances

16.5.9. R&D and Innovation

16.5.10. Recent Developments

16.5.11. SWOT Snapshot

16.6. Epic Systems

16.6.1. Overview (HQ, Ownership, Founding Year, Workforce Estimate)

16.6.2. Geographic Footprint

16.6.3. Product and Service Portfolio

16.6.4. Target Customer Segments

16.6.5. Distribution and GTM

16.6.6. Key Financials

16.6.7. Certifications

16.6.8. Partnerships and Alliances

16.6.9. R&D and Innovation

16.6.10. Recent Developments

16.6.11. SWOT Snapshot

16.7. Siemens Healthineers

16.7.1. Overview (HQ, Ownership, Founding Year, Workforce Estimate)

16.7.2. Geographic Footprint

16.7.3. Product and Service Portfolio

16.7.4. Target Customer Segments

16.7.5. Distribution and GTM

16.7.6. Key Financials

16.7.7. Certifications

16.7.8. Partnerships and Alliances

16.7.9. R&D and Innovation

16.7.10. Recent Developments

16.7.11. SWOT Snapshot

16.8. Brainlab

16.8.1. Overview (HQ, Ownership, Founding Year, Workforce Estimate)

16.8.2. Geographic Footprint

16.8.3. Product and Service Portfolio

16.8.4. Target Customer Segments

16.8.5. Distribution and GTM

16.8.6. Key Financials

16.8.7. Certifications

16.8.8. Partnerships and Alliances

16.8.9. R&D and Innovation

16.8.10. Recent Developments

16.8.11. SWOT Snapshot

16.9. InterSystems

16.9.1. Overview (HQ, Ownership, Founding Year, Workforce Estimate)

16.9.2. Geographic Footprint

16.9.3. Product and Service Portfolio

16.9.4. Target Customer Segments

16.9.5. Distribution and GTM

16.9.6. Key Financials

16.9.7. Certifications

16.9.8. Partnerships and Alliances

16.9.9. R&D and Innovation

16.9.10. Recent Developments

16.9.11. SWOT Snapshot

16.10. MV Informatica

16.10.1. Overview (HQ, Ownership, Founding Year, Workforce Estimate)

16.10.2. Geographic Footprint

16.10.3. Product and Service Portfolio

16.10.4. Target Customer Segments

16.10.5. Distribution and GTM

16.10.6. Key Financials

16.10.7. Certifications

16.10.8. Partnerships and Alliances

16.10.9. R&D and Innovation

16.10.10. Recent Developments

16.10.11. SWOT Snapshot

16.11. Benner Saude

16.11.1. Overview (HQ, Ownership, Founding Year, Workforce Estimate)

16.11.2. Geographic Footprint

16.11.3. Product and Service Portfolio

16.11.4. Target Customer Segments

16.11.5. Distribution and GTM

16.11.6. Key Financials

16.11.7. Certifications

16.11.8. Partnerships and Alliances

16.11.9. R&D and Innovation

16.11.10. Recent Developments

16.11.11. SWOT Snapshot

16.12. Pixeon

16.12.1. Overview (HQ, Ownership, Founding Year, Workforce Estimate)

16.12.2. Geographic Footprint

16.12.3. Product and Service Portfolio

16.12.4. Target Customer Segments

16.12.5. Distribution and GTM

16.12.6. Key Financials

16.12.7. Certifications

16.12.8. Partnerships and Alliances

16.12.9. R&D and Innovation

16.12.10. Recent Developments

16.12.11. SWOT Snapshot

16.13. TOTVS Saude

16.13.1. Overview (HQ, Ownership, Founding Year, Workforce Estimate)

16.13.2. Geographic Footprint

16.13.3. Product and Service Portfolio

16.13.4. Target Customer Segments

16.13.5. Distribution and GTM

16.13.6. Key Financials

16.13.7. Certifications

16.13.8. Partnerships and Alliances

16.13.9. R&D and Innovation

16.13.10. Recent Developments

16.13.11. SWOT Snapshot

16.14. Cerner Enviza

16.14.1. Overview (HQ, Ownership, Founding Year, Workforce Estimate)

16.14.2. Geographic Footprint

16.14.3. Product and Service Portfolio

16.14.4. Target Customer Segments

16.14.5. Distribution and GTM

16.14.6. Key Financials

16.14.7. Certifications

16.14.8. Partnerships and Alliances

16.14.9. R&D and Innovation

16.14.10. Recent Developments

16.14.11. SWOT Snapshot

16.15. Instituto de Cancer Dr. Arnaldo

16.15.1. Overview (HQ, Ownership, Founding Year, Workforce Estimate)

16.15.2. Geographic Footprint

16.15.3. Product and Service Portfolio

16.15.4. Target Customer Segments

16.15.5. Distribution and GTM

16.15.6. Key Financials

16.15.7. Certifications

16.15.8. Partnerships and Alliances

16.15.9. R&D and Innovation

16.15.10. Recent Developments

16.15.11. SWOT Snapshot

Frequently Asked Questions

The market is estimated at approximately USD 115 million in 2025 and is projected to reach approximately USD 173 million by 2030, growing at around 8.5 percent annually.

Rapid hospital digitalization programs, growing radiotherapy infrastructure investment and rising demand for interoperability with imaging and electronic medical record systems are the primary drivers.

Radiation oncology information systems, medical oncology information systems, integrated oncology care platforms, oncology electronic medical records and oncology workflow automation platforms are the main system types.

Elekta, Varian Medical Systems, RaySearch Laboratories, Philips Healthcare, Oracle Health and Epic Systems are among the largest global players, alongside Brazilian specialists such as MV Informatica, Pixeon and TOTVS Saude.

Sao Paulo leads adoption, anchored by the Sao Paulo Metropolitan Oncology Network and Campinas Healthcare Technology Corridor, followed by the Barretos Oncology and Research Cluster and Southern Brazil's private hospital networks.

Inquire Before Buying Request Free Sample Ask For Discount

Research Methodology

Public market forecasts

Public research estimates sizing the Brazil oncology information systems market at approximately USD 106.2 million in 2024, projected to reach approximately USD 172.8 million by 2030 at an 8.5% CAGR from 2025 to 2030, were used as the primary anchor for this report, an unusually direct match to this report's own scope requiring minimal narrowing.

Base year adjustment

The 2024 base figure was rolled forward to a 2025 base year using the same 8.5% growth rate, producing an estimated 2025 market size of approximately USD 115 million, consistent with the reported 2030 endpoint of approximately USD 173 million.

Segment-share derivation

System type, deployment model and institution type relationships identified in the segmentation framework were applied to the triangulated base estimate to produce internally consistent segment behavior, cross-checked against Brazil's reported 3.6% share of the global oncology information systems market and its leading position within Latin America.

Growth rate reconciliation

The forecast CAGR of approximately 8.5% is consistent with public reporting that Brazil has historically grown faster than the broader Latin America oncology information systems market, reflecting the country's concentrated base of high-volume oncology infrastructure and accelerating hospital digitalization investment.

Frequently Asked Questions

The market is estimated at approximately USD 115 million in 2025 and is projected to reach approximately USD 173 million by 2030, growing at around 8.5 percent annually.

Rapid hospital digitalization programs, growing radiotherapy infrastructure investment and rising demand for interoperability with imaging and electronic medical record systems are the primary drivers.

Radiation oncology information systems, medical oncology information systems, integrated oncology care platforms, oncology electronic medical records and oncology workflow automation platforms are the main system types.

Elekta, Varian Medical Systems, RaySearch Laboratories, Philips Healthcare, Oracle Health and Epic Systems are among the largest global players, alongside Brazilian specialists such as MV Informatica, Pixeon and TOTVS Saude.

Sao Paulo leads adoption, anchored by the Sao Paulo Metropolitan Oncology Network and Campinas Healthcare Technology Corridor, followed by the Barretos Oncology and Research Cluster and Southern Brazil's private hospital networks.

Inquire Before Buying Request Free Sample Ask For Discount